Naoki Okamura, Astellas CEO
April 30, 2023 08:07 PM EDTUpdated 06:46 AM
Deals
Pharma

Astel­las to buy Iver­ic Bio for $5.9B in cash as biotech awaits Au­gust FDA nod in reti­nal dis­ease

Kyle LaHucik

Senior Reporter

Astel­las Phar­ma will buy New Jer­sey biotech Iver­ic Bio for $40 per share in cash, the com­pa­nies said Sun­day night, set­ting …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times